UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition

EBioMedicine, 2019-03, Vol.41, p.711-716

2019

Volltextzugriff (PDF)

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1556-1563

2011

Volltextzugriff (PDF)

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

Journal of clinical oncology, 2012-02, Vol.30 (5), p.525-532

2012

Volltextzugriff (PDF)

Vasculogenic mimicry in small cell lung cancer

Nature communications, 2016-11, Vol.7 (1), p.13322-13322, Article 13322

2016

Volltextzugriff (PDF)

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1067-1074

2011

Volltextzugriff (PDF)

A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: a patient unmet need

BMC cancer, 2020-01, Vol.20 (1), p.9-9, Article 9

2020

Volltextzugriff (PDF)

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

The American journal of pathology, 2009-08, Vol.175 (2), p.808-816

2009

Volltextzugriff (PDF)

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-12, Vol.25 (35), p.5562-5569

2007

Volltextzugriff (PDF)

Circulating tumour cells: their utility in cancer management and predicting outcomes

Therapeutic Advances in Medical Oncology, 2010-11, Vol.2 (6), p.351-365

2010

Volltextzugriff (PDF)

Variant Ciz1 is a circulating biomarker for early-stage lung cancer

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (45), p.E3128-E3135

2012

Volltextzugriff (PDF)

Direct Ras G12C inhibitors: crossing the rubicon

British journal of cancer, 2019-07, Vol.121 (3), p.197-198

2019

Volltextzugriff (PDF)

K-ras mutations in non-small-cell lung carcinoma: a review

Clinical lung cancer, 2006-07, Vol.8 (1), p.30-38

2006

Volltextzugriff (PDF)

Liquid Chromatography–Mass Spectrometry Calibration Transfer and Metabolomics Data Fusion

Analytical chemistry (Washington), 2012-11, Vol.84 (22), p.9848-9857

2012

Volltextzugriff (PDF)

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2858-2865

2016

Volltextzugriff (PDF)

Diagnostic Mutation Profiling and Validation of Non–Small-Cell Lung Cancer Small Biopsy Samples using a High Throughput Platform

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.784-792

2015

Volltextzugriff (PDF)

Distribution and Clinical Significance of Heparan Sulfate Proteoglycans in Ovarian Cancer

Clinical cancer research, 2004-08, Vol.10 (15), p.5178-5186

2004

Volltextzugriff (PDF)

Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor

Journal of endocrinology, 2008-09, Vol.198 (3), p.499-509

2008

Volltextzugriff (PDF)

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Journal of thoracic oncology, 2012-02, Vol.7 (2), p.306-315

2012

Volltextzugriff (PDF)

Expression and Prognostic Significance of Kit, Protein Kinase B, and Mitogen-activated Protein Kinase in Patients with Small Cell Lung Cancer

Clinical cancer research, 2003-06, Vol.9 (6), p.2241-2247

2003

Volltextzugriff (PDF)

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2780-2787

2014

Volltextzugriff (PDF)

Cough in Patients With Lung Cancer: A Longitudinal Observational Study of Characterization and Clinical Associations

Chest, 2019-01, Vol.155 (1), p.103

2019

Volltextzugriff (PDF)

Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy

Cancer treatment reviews, 2012-10, Vol.38 (6), p.626-640

2012

Volltextzugriff (PDF)

Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value

EBioMedicine, 2015-08, Vol.2 (8), p.841-850

2015

Volltextzugriff (PDF)

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-04, Vol.76 (1), p.19-25

2012

Volltextzugriff (PDF)

Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker

Clinical cancer research, 2004-03, Vol.10 (6), p.1984-1991

2004

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(121)

Sprache

Englisch
(119)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Humans
(70)
Life Sciences & Biomedicine
(70)
Cough
(36)
Oncology
(33)
Adult
(32)
Respiratory System
(31)
Female
(29)
Evidence-Based Medicine
(27)
Male
(26)
Aged
(25)
General & Internal Medicine
(25)
Middle Aged
(25)
Critical Care Medicine
(23)
Biological And Medical Sciences
(18)
Cough - Etiology
(17)
Lung Neoplasms - Pathology
(17)
Medical Sciences
(17)
Lung Cancer
(16)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

Vasculogenic mimicry in small cell lung cancer

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: a patient unmet need

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

Circulating tumour cells: their utility in cancer management and predicting outcomes

Variant Ciz1 is a circulating biomarker for early-stage lung cancer

Direct Ras G12C inhibitors: crossing the rubicon

K-ras mutations in non-small-cell lung carcinoma: a review

Liquid Chromatography–Mass Spectrometry Calibration Transfer and Metabolomics Data Fusion

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014

Diagnostic Mutation Profiling and Validation of Non–Small-Cell Lung Cancer Small Biopsy Samples using a High Throughput Platform

Distribution and Clinical Significance of Heparan Sulfate Proteoglycans in Ovarian Cancer

Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Expression and Prognostic Significance of Kit, Protein Kinase B, and Mitogen-activated Protein Kinase in Patients with Small Cell Lung Cancer

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Cough in Patients With Lung Cancer: A Longitudinal Observational Study of Characterization and Clinical Associations

Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy

Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker

Suchergebnisse filtern